EFFECTS OF METFORMIN IN OBESE PATIENTS WITH IMPAIRED GLUCOSE-TOLERANCE

被引:12
作者
SCHEEN, AJ
LETIEXHE, MR
LEFEBVRE, PJ
机构
[1] Division of Diabetes, Nutrition and Metabolic Disorders, Department of Medicine, CHU Liège
来源
DIABETES-METABOLISM REVIEWS | 1995年 / 11卷
关键词
D O I
10.1002/dmr.5610110511
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:S69 / S80
页数:12
相关论文
共 75 条
  • [1] Golay A, Felber JP, Evolution from obesity to diabetes, Diabete Metab, 20, pp. 3-14, (1994)
  • [2] Scheen AJ, From obesity to type 2 diabetes, Acta Clin Belg, 47, 14, pp. 30-36, (1992)
  • [3] Scheen AJ, Lefebvre PJ, De l'obésité au diabète ou de l'insulinorésistance au déficit insulinosécrétoire, Rev Fr Endocrinol Clin, 34, pp. 297-310, (1993)
  • [4] Lillioja S, Bogardus C, Obesity and insulin resistance: lessons learned from the Pima indians, Diabetes Metab Rev, 4, pp. 517-540, (1988)
  • [5] Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E, Knowler WC, Bennett PH, Bogardus C, Insulin resistance and insulin secretory dysfunction as precursors of non‐insulin‐dependent diabetes mellitus: prospective studies of Pima indians, N Engl J Med, 329, pp. 1988-1992, (1983)
  • [6] Reaven GM, Role of insulin resistance in human disease, Diabetes, 37, pp. 1595-1607, (1988)
  • [7] Beck-Nielsen H, Groop LC, Metabolic and genetic characterization of prediabetic states: sequence of events leading to non‐insulin‐dependent diabetes mellitus, Journal of Clinical Investigation, 94, pp. 1714-1721, (1994)
  • [8] DeFronzo RA, Bonadonna RC, Ferrannini E, Pathogenesis of NIDDM: a balanced overview, Diabetes Care, 15, pp. 318-368, (1992)
  • [9] Bailey CJ, Biguanides and NIDDM, Diabetes Care, 15, pp. 755-772, (1992)
  • [10] Hermann LS, Melander A, Biguanides: basic aspects and clinical uses, International Textbook of Diabetes Mellitus, pp. 773-775, (1992)